59
Views
2
CrossRef citations to date
0
Altmetric
Review

Ocular complications in Ebola virus disease survivors: the importance of continuing care in West Africa

, , &
Pages 179-185 | Received 24 Nov 2018, Accepted 21 May 2019, Published online: 04 Jun 2019

References

  • World Health Organization. Ebola situation reports: democratic Republic of the Congo. https://www.who.int/ebola/situation-reports/drc-2018/en/. April 21 2019.
  • World Health Organization. Ebola Virus Disease: fact Sheet. http://www.who.int/news-room/fact-sheets/detail/ebola-virus-disease. November 13 2018.
  • Mattia JG, Vandy MJ, Chang JC, et al. Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study. Lancet Infect Dis. 2016;16:331–338.
  • Nanyonga M, Saidu J, Ramsay A, et al. Sequelae of Ebola Virus Disease, Kenema District, Sierra Leone. Clin Infect Dis. 2016;62:125–126.
  • Vetter P, Kaiser L, Schibler M, et al. Sequelae of Ebola virus disease: the emergency within the emergency. Lancet Infect Dis. 2016;16:e82–e91.
  • Steptoe PJ, Scott JT, Baxter JM, et al. Novel Retinal Lesion in Ebola Survivors, Sierra Leone, 2016. Emerg Infect Dis. 2017;23:1102–1109.
  • Howlett PJ, Walder AR, Lisk DR, et al. Case Series of Severe Neurologic Sequelae of Ebola Virus Disease during Epidemic, Sierra Leone. Emerg Infect Dis. 2018;24:1412–1421.
  • Shantha JG, Crozier I, Hayek BR, et al. Ophthalmic Manifestations and Causes of Vision Impairment in Ebola Virus Disease Survivors in Monrovia, Liberia. Ophthalmology. 2017;124:170–177.
  • Goldstein T, Anthony SJ, Gbakima A, et al. The discovery of Bombali virus adds further support for bats as hosts of ebolaviruses. Nat Microbiol. 2018;3:1084–1089.
  • Vine V, Scott DP, Feldmann H. Ebolavirus: an Overview of Molecular and Clinical Pathogenesis. Methods Mol Biol. 2017;1628:39–50.
  • Kibadi K, Mupapa K, Kuvula K, et al. Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, Democratic Republic of the Congo. J Infect Dis. 1999;179 Suppl 1:S13–14.
  • Semper AE, Broadhurst MJ, Richards J, et al. Performance of the GeneXpert Ebola Assay for Diagnosis of Ebola Virus Disease in Sierra Leone: A Field Evaluation Study. PLoS Med. 2016;13:e1001980.
  • Hayden FG. Friede M and Bausch DG. Experimental Therapies for Ebola Virus Disease: what Have We Learned?. J Infect Dis. 2017;215:167–170.
  • Etard JF, Sow MS, Leroy S, et al. Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study. Lancet Infect Dis. 2017;17:545–552.
  • Clark DV, Kibuuka H, Millard M, et al. Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study. Lancet Infect Dis. 2015;15:905–912.
  • Tiffany A, Vetter P, Mattia J, et al. Ebola Virus Disease Complications as Experienced by Survivors in Sierra Leone. Clin Infect Dis. 2016;62:1360–1366.
  • Mohammed H, Vandy AO, Stretch R, et al. Sequelae and Other Conditions in Ebola Virus Disease Survivors, Sierra Leone, 2015. Emerg Infect Dis. 2017;23:66–73.
  • Rodriguez LL, De Roo A, Guimard Y, et al. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis. 1999;179(Suppl 1):S170–176.
  • Bausch DG, Towner JS, Dowell SF, et al. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis. 2007;196(Suppl 2):S142–147.
  • Zeng X, Blancett CD, Koistinen KA, et al. Identification and pathological characterization of persistent asymptomatic Ebola virus infection in rhesus monkeys. Nat Microbiol. 2017;2:17113.
  • Varkey JB, Shantha JG, Crozier I, et al. Persistence of Ebola Virus in Ocular Fluid during Convalescence. N Engl J Med. 2015;372:2423–2427.
  • Smith JR, Todd S, Ashander LM, et al. Retinal Pigment Epithelial Cells are a Potential Reservoir for Ebola Virus in the Human Eye. Transl Vis Sci Technol. 2017;6:12.
  • Shantha JG, Mattia JG, Goba A, et al. Ebola Virus Persistence in Ocular Tissues and Fluids (EVICT) Study: reverse Transcription-Polymerase Chain Reaction and Cataract Surgery Outcomes of Ebola Survivors in Sierra Leone. EBioMedicine. 2018;30:217–224.
  • Jacobs M, Rodger A, Bell DJ, et al. Late Ebola virus relapse causing meningoencephalitis: a case report. Lancet. 2016;388:498–503.
  • Purpura LJ, Rogers E, Baller A, et al. Ebola Virus RNA in Semen from an HIV-Positive Survivor of Ebola. Emerg Infect Dis. 2017;23:714–715.
  • Diallo B, Sissoko D, Loman NJ, et al. Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor With Virus Persistence in Seminal Fluid for More Than 500 Days. Clin Infect Dis. 2016;63:1353–1356.
  • Deen GF, Broutet N, Xu W, et al. Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors - Final Report. N Engl J Med. 2017;377:1428–1437.
  • Sissoko D, Keita M, Diallo B, et al. Ebola Virus Persistence in Breast Milk After No Reported Illness: A Likely Source of Virus Transmission From Mother to Child. Clin Infect Dis. 2017;64:513–516.
  • Hereth-Hebert E, Bah MO, Etard JF, et al. Ocular Complications in Survivors of the Ebola Outbreak in Guinea. Am J Ophthalmol. 2017;175:114–121.
  • Steptoe PJ, Scott JT, Harding SP, et al. Ocular Complications in Survivors of the Ebola Outbreak in Guinea. Am J Ophthalmol. 2017;181:180.
  • Steptoe PJ, Momorie F, Fornah AD, et al. Multimodal Imaging and Spatial Analysis of Ebola Retinal Lesions in 14 Survivors of Ebola Virus Disease. JAMA Ophthalmol. 2018;136:689–693.
  • Wilson HW, Amo-Addae M, Kenu E, et al. Post-Ebola Syndrome among Ebola Virus Disease Survivors in Montserrado County, Liberia 2016. Biomed Res Int. 2018;2018:1909410.
  • Chancellor JR, Padmanabhan SP, Greenough TC, et al. Uveitis and Systemic Inflammatory Markers in Convalescent Phase of Ebola Virus Disease. Emerg Infect Dis. 2016;22:295–297.
  • Shantha JG, Crozier I, Varkey JB, et al. Long-term Management of Panuveitis and Iris Heterochromia in an Ebola Survivor. Ophthalmology. 2016;123:2626–2628e2622.
  • World Health Organization. Clinical care for survivors of Ebola virus disease. http://www.who.int/csr/resources/publications/ebola/guidance-survivors/en/. November 4 2018.
  • Yeh S, Shantha JG, Hayek B, et al. Clinical Manifestations and Pathogenesis of Uveitis in Ebola Virus Disease Survivors. Ocul Immunol Inflamm. 2018;26:1128–1134.
  • de St Maurice A, Ervin E, Orone R, et al. Care of Ebola Survivors and Factors Associated With Clinical Sequelae-Monrovia, Liberia. Open Forum Infect Dis. 2018;5:ofy239.
  • World Health Organization. DIsease outbreaks by year. http://www.who.int/csr/don/archive/year/2018/en/. November 6 2018.
  • WoolhouseME, BrierleyL, McCafferyC, etal. Assessing the Epidemic Potential of RNA and DNA Viruses. Emerg Infect Dis. 2016;22:2037–2044.
  • De Groot-Mijnes JDF, Chan ASY. Chee SP and Verjans G. Immunopathology of Virus-Induced Anterior Uveitis. Ocul Immunol Inflamm. 2018;26:338–346.
  • Connors DB, Shantha JG, Yeh S. Emerging causes of viral-associated uveitis. Int Ophthalmol Clin. 2015;55:103–113.
  • Strong JE, Wong G, Jones SE, et al. Stimulation of Ebola virus production from persistent infection through activation of the Ras/MAPK pathway. Proc Natl Acad Sci U S A.2008;105:17982–17987.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.